©The Author(s) 2025.
World J Gastroenterol. Nov 14, 2025; 31(42): 112577
Published online Nov 14, 2025. doi: 10.3748/wjg.v31.i42.112577
Published online Nov 14, 2025. doi: 10.3748/wjg.v31.i42.112577
Table 6 Adherence assessment of the study participants, n (%)
| Time points | Good compliance |
| After 2 weeks of intervention | |
| Intervention group (n = 82) | 77 (93.9) |
| Placebo-controlled group (n = 79) | 70 (88.6) |
| Total population (n = 161) | 147 (91.3) |
| After 4 weeks of intervention | |
| Intervention group (n = 78) | 70 (89.7) |
| Placebo-controlled group (n = 76) | 67 (88.2) |
| Total population (n = 154) | 137 (89.0) |
- Citation: Liu WJ, Zhao YM, Xie QQ, Wu MC, Pan YF, Yan HK, Shan XX, Xu WT, Liu YL, Peng CX, Zhang XM, Lin Q. Multistrain probiotics alleviate gastrointestinal symptoms during bismuth quadruple therapy for Helicobacter pylori infection. World J Gastroenterol 2025; 31(42): 112577
- URL: https://www.wjgnet.com/1007-9327/full/v31/i42/112577.htm
- DOI: https://dx.doi.org/10.3748/wjg.v31.i42.112577